Irritable pouch syndrome is characterized by visceral hypersensitivity

Inflammatory Bowel Diseases

Volumn 17, Issue 4, 2011, Pages 994-1002

  Shen, Bo ^a   Sanmiguel, Claudia ^b   Bennett, Ana E ^a   Lian, Lei ^a   Larive, Brett ^a   Remzi, Feza H ^a   Fazio, Victor W ^a   Soffer, Edy E ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Barostat; Ileal pouch; Restorative proctocolectomy; Tone; Visceral hypersensitivity

Indexed keywords

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ARTICLE; BIOMECHANICS; BLOATING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DEFECATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEITIS; ILEOANAL ANASTOMOSIS; ILEOSTOMY; ILEUM POUCH; INTESTINE FUNCTION DISORDER; INTESTINE PARAMETERS; IRRITABLE POUCH SYNDROME; MALE; POUCH COMPLIANCE; POUCH TONE; POUCHITIS DISEASE ACTIVITY INDEX; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; ULCERATIVE COLITIS; VISCERAL HYPERSENSITIVITY; VISUAL ANALOG SCALE;

CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERSENSITIVITY; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE; PROGNOSIS; QUALITY OF LIFE;

EID: 79952470218     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21412     Document Type: Article

References (46)

1. Loftus EV Jr, Friedman HS, Delgado DJ, et al. Colectomy subtypes, follow-up surgical procedures, postsurgical complications, and medical charges among ulcerative colitis patients with private health insurance in the United States. Inflamm Bowel Dis. 2009;15: 566-575.
2. Shen B, Achkar J-P, Lashner BA, et al. Irritable pouch syndrome: A new category of diagnosis for symptomatic patients with ileal pouchanal anastomosis. Am J Gastroenterol. 2002;97:972-977. (Pubitemid 34408256)
3. Sandborn WJ, Pardi D. Clinical management of pouchitis. Gastroenterology. 2004;127;1809-1814. (Pubitemid 39575859)
4. Mahadevan U, Sandborn WJ. Diagnosis and management of pouchitis. Gastroenterology. 2003;124:1636-1650. (Pubitemid 36617682)
5. Schmidt C, Hauser W, Giese T, et al. Irritable pouch syndrome is associated with depressiveness and can be differentiated from pouchitis by quantification of mucosal levels of proinflammatory gene transcripts. Inflamm Bowel Dis. 2007;13:1502-1508.
6. Shen B, Yu CH, Lian L, et al. Development of a nomogram for prediction of pouch failure in ulcerative colitis patients with restorative proctocolectomy. Gastroenterology 2010;138;S531.
7. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804-811
8. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002; 122:1778-1783. (Pubitemid 34651421)
9. Shen B, Liu W PhD, Remzi FH, et al. Enterochromaffin cell hyperplasia in irritable pouch syndrome. Am J Gastroenterol. 2008;103: 2293-2300
10. Mertz H, Naliboff B, Munakata J, et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology. 1995;109:40-52.
11. Trimble KC, Farouk R, Pryde A, et al. Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity. Dig Dis Sci. 1995;40: 1607-1613.
12. Shen B, Remzi FH, Lavery IC, et al. A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy for ulcerative colitis. Clin Gastroenterol Hepatol. 2008;6: 145-158. (Pubitemid 351172940)
13. Fazio VW, O'Riordain MG, Lavery IC, et al. Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Ann Surg. 1999;230:575-584.
14. Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastomosis: A pouchitis disease activity index. Mayo Clin Proc. 1994;69:409-415.
15. Minderhoud IM, Oldenburg B, Wismeijer JA, et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci. 2004; 49:469-474. (Pubitemid 38453568)
16. Bharucha AE, Camilleri M, Zinsmeister AR, et al. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol. 1997;273:G997-1006.
17. Sweetser S, Busciglio IA, Camilleri M, et al. Effect of chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects. Am J Physiol. 2008;296:G295-G301.
18. Shen B, Fazio VW, Remzi FH, et al. Comprehensive evaluation of inflammatory and non-inflammatory sequelae of ileal pouch-anal anastomosis. Am J Gastroenterol. 2005;100:93-101. (Pubitemid 41623275)
19. Drossman DA, Camilleri M, Mayer MA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108-2131. (Pubitemid 35408332)
20. Shen B, Fazio VW, Remzi FH, et al. Risk factors for clinical phenotypes of Crohn's disease of the pouch. Am J Gastroenterol. 2006;101: 2760-2768. (Pubitemid 44902648)
21. Steen J, Penning C, Brussee J, et al. Prospective evaluation of ileoanal pouch characteristics measured by barostat. Dis Colon Rectum. 2002; 45:1295-1303. (Pubitemid 35176038)
22. Steens J, Bemelman WA, Meijerink WJHJ, et al. Ileoanal pouch function is related with postprandial pouch tone. Br J Surg. 2001;88: 1492-1497. (Pubitemid 32989470)
23. Bernstein CN, Rollandilli R, Niazi N, et al. Characterization of afferent mechanisms in ileoanal pouches. Am J Gastroenterol. 1997;92: 103-108. (Pubitemid 27027038)
24. Whitehead WE, Delvaux M. Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK. Dig Dis Sci. 1997;42:223-241. (Pubitemid 27112964)
25. Kellow JE, Azpiroz F, Delvaux M, et al. Applied principles of neurogastroenterology: physiology/motility sensation. Gastroenterology. 2006;130:1412-1420.
26. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable bowel syndrome. Gut. 1973;6:105-112.
27. Prior A, Sorial E, Sun WM, et al. Irritable bowel syndrome: differences between patients who show rectal sensitivity and those who do not. Eur J Gastroenterol Hepatol. 1993;5:343-349. (Pubitemid 23134386)
28. Bradette M, Delvaux M, Staumont G, et al. Evaluation of colonic sensory thresholds in IBS patients using a barostat. Definition of optimal conditions and comparison with healthy subjects. Dig Dis Sci. 1994; 39:449-457.
29. Zighelboim J, Talley NJ, Phillips SF, et al. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci. 1995;40:819-827.
30. Accarino AM, Azpiroz F, Malagelada AR. Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome. Gastroenterology. 1995;108:636-643.
31. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol. 2003;98:1578-1583. (Pubitemid 36875351)
32. O'Sullivan M, Clayton N, Breslin NP, et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil. 2000;12:449-457.
33. Wang LH, Fang XC, Pan GC. Bacillary dysentery as a causative factor of irritable bowel syndrom and its pathogenesis. Gut. 2004;53: 1096-1101.
34. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693-702. (Pubitemid 38298317)
35. Barbara G, Wang,B, Stanghellini V, et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology. 2007;132:26-37. (Pubitemid 46108761)
36. Santos J, Guilarte M, Alonso C, et al. Pathogenesis of irritable bowel syndrome: The mast cell connection. Scand J Gastroenterol. 2005;40: 129-140. (Pubitemid 40192572)
37. Park JH, Rhee PL, Kim HS, et al. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J Gastroenterol Hepatol. 2006;21:71-78.
38. Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125: 19-31. (Pubitemid 36799103)
39. Murray CDR, Flynn J, Ratcliffe L, et al. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology. 2004;127:1695-1703. (Pubitemid 39575848)
40. Posserud I, Ringstrom G, Agerforz P, et al. Visceral hypersensitivity and relation to symptoms in the irritable bowel syndrome (IBS). Gastroenterology. 2003;A14.
41. Simren M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002;97:389-396. (Pubitemid 34160766)
42. Isgar B, Hartman M, Kaye MD, et al. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983;24:190-192. (Pubitemid 13147731)
43. Camilleri M, McKinzie S, Busciglio I, et al. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2008;6: 772-781.
44. Shepherd NA, Healey CJ, Warren BF, et al. Distribution of mucosal morphology and an assessment of colonic phenotype change in the pelvic ileal reservoir. Gut. 1993;34:101-105. (Pubitemid 23015959)
45. Biancone L, Palmieri G, Lombardi A, et al. Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis. Am J Gastroenterol. 2003;98:2719-2726. (Pubitemid 38020114)
46. Tysk C, Riedesel H, Lindberg E, et al. Colonic glycoproteins in monozygote twins with inflammatory bowel disease. Gastroenterology. 1991;100:1509-1514.